The key to these vaccines appears to be neoantigens in the pancreatic tumors, which alert the immune system to keep the cancer at bay.

Leprosy is one of the world’s oldest and most persistent diseases but the bacteria that cause it may also have the surprising ability.

Doctors in the UK hope that thousands of men with prostate cancer could be cured through an innovative hour-long operation.

Researchers are one step closer to making a multi-cancer early detection (MCED) test, that can detect over 50 types of cancer.

New research using pet dogs could pave the way for a new immunotherapy treatment for one of the most common childhood cancers, Sarcoma.

The work also shows how a new technique—single-cell analysis—can detect tumours at very early stages, or a predisposition to developing them

New research about how cancer-related proteins bind the metal and how they interact with other proteins, opens up potential new drug targets

Parkinson’s disease, which accounts for 5–10% of all PD cases, affects 3% of population over 65 years old with an average onset at 60.

Scientists investigating the mechanics of the early stages of lung cancer have identified a new potential treatment aiding early detection.

A new technology enables the body to produce therapeutic agents on demand at the exact location where they are needed.

A rare gene in the tumors of some colorectal cancer patients could lead to more accurate diagnoses and, eventually, personalized treatments.

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor.

Vaccination with senescent cells significantly reduces the development of tumours in experimental models of melanoma and pancreatic cancer.

Stanford University researchers have discovered a rapid and sustainable way to synthetically produce a promising cancer-fighting compound.

Dramatic results in glioblastoma research: eliminating the astrocytes surrounding the tumors resulted in cancer cell death.

A trial in people with high hereditary risk of a wide range of cancers has shown a major preventive effect from resistant starch.

Researchers developed a new synthetic molecule that combines a tumor-targeting agent with another molecule that triggers immune activation.

Rice University and Baylor College of Medicine researchers have shown they can eradicate advanced-stage mesothelioma tumors in just days.

Triple negative breast cancer accounts for 10 to 15% of all breast cancers and affects 225,000 patients per year worldwide.

Understanding the molecular mechanisms of metastasis is therefore a key piece of the puzzle in the fight against cancer.